Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study

Introduction: Since the coronavirus disease 2019 (COVID-19) pandemic, the use of angiotensin II receptor blockers (ARBs) in hypertensive patients with COVID-19 has been controversial. Following our previous study, after one year, we intended to extend our sample size and results to investigate the e...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Azar Hadadi, Sina Kazemian, Mahan Shafie, Arezoo Ahmadi, Abbas Soleimani, Haleh Ashraf
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Tabriz University of Medical Sciences 2022-12-01
Ráidu:	Journal of Cardiovascular and Thoracic Research
Fáttát:	angiotensin-converting enzyme inhibitors covid-19 hypertension renin-angiotensin system sars-cov-2
Liŋkkat:	https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-14-253.pdf
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!